Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Winfield › NPI 1396901088
Physician

Patel, Ajay

Patel, Ajay was paid $4.27M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 9.1% of everything it billed.

33Billing provider infoPATEL, AJAY
WINFIELD, IL 60190
33aNPI1396901088assigned 08/01/2008
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$4.27M
24GClaims590,866
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#13 of 398
Median peer was paid$66K
This provider vs. median65×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018263$6K
2019286$9K
2020116,088$782K
2021195,162$1.43M
202294,107$854K
202398,680$703K
2024incomplete86,280$489K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0202U Oncology (prostate), multianalyte, gene expression profiling 9.1% 1,832 1,640 $390K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 9.0% 13,026 10,549 $383K
80053 Comprehensive metabolic panel 8.6% 71,838 46,272 $368K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 7.8% 4,268 4,101 $335K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.6% 10,011 7,738 $238K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5.4% 81,181 49,776 $231K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.9% 1,984 1,609 $123K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.7% 2,228 1,891 $114K
84443 Thyroid stimulating hormone (TSH) 2.7% 13,948 11,380 $114K
80048 Basic metabolic panel (calcium, ionized) 2.5% 25,749 10,387 $106K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.2% 4,240 4,081 $93K
87507 2.1% 542 509 $90K
241 more codes
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.8% 2,783 $77K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.8% 449 $76K
83735 1.7% 22,078 $74K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.4% 2,654 $60K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.4% 1,560 $59K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.4% 2,635 $59K
85027 1.3% 19,263 $55K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.0% 5,782 $44K
87040 1.0% 4,713 $44K
84484 1.0% 9,988 $43K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,104 $41K
82803 <1% 4,228 $40K
82962 <1% 20,349 $33K
81001 <1% 23,370 $33K
87631 <1% 606 $32K
80061 Lipid panel <1% 9,001 $32K
83880 <1% 2,661 $30K
83690 <1% 8,757 $29K
85379 <1% 7,627 $28K
84703 <1% 7,242 $26K
82607 <1% 3,981 $24K
86140 <1% 10,165 $24K
81025 <1% 9,146 $22K
86850 <1% 7,242 $21K
83036 Hemoglobin; glycosylated (A1C) <1% 6,916 $21K
87186 <1% 3,327 $20K
82728 <1% 4,818 $19K
83605 <1% 3,961 $19K
84439 <1% 4,283 $19K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 592 $18K
86901 <1% 8,001 $18K
85610 <1% 9,122 $18K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,122 $16K
83615 <1% 5,284 $14K
86900 <1% 8,002 $14K
82746 <1% 2,339 $13K
84100 <1% 6,211 $13K
84466 <1% 2,922 $13K
87481 <1% 303 $12K
87799 <1% 255 $12K
87581 <1% 519 $12K
87486 <1% 516 $12K
85730 <1% 3,802 $12K
87075 <1% 1,715 $11K
84702 <1% 2,330 $10K
86803 <1% 1,254 $10K
87070 <1% 3,072 $10K
83540 <1% 3,036 $10K
87480 <1% 740 $10K
87510 <1% 737 $10K
87340 <1% 1,410 $9K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 646 $9K
86480 <1% 352 $9K
82330 <1% 1,214 $9K
82550 <1% 2,836 $8K
86769 <1% 295 $7K
84403 <1% 559 $7K
84481 <1% 1,405 $7K
85652 <1% 5,015 $6K
86038 <1% 829 $6K
82570 <1% 2,705 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 255 $6K
87660 <1% 737 $6K
87088 <1% 1,098 $6K
87205 <1% 3,146 $6K
83970 <1% 331 $5K
84145 <1% 1,028 $5K
87512 <1% 277 $5K
84550 <1% 2,400 $5K
83516 <1% 747 $5K
83001 <1% 496 $4K
83655 <1% 755 $4K
82565 <1% 1,993 $4K
82784 <1% 683 $4K
80076 <1% 1,150 $4K
85384 <1% 1,341 $4K
87081 <1% 1,356 $4K
82248 <1% 1,943 $4K
86592 <1% 1,782 $4K
84132 <1% 1,823 $3K
81003 <1% 3,050 $3K
83021 <1% 532 $3K
84146 <1% 431 $3K
84153 <1% 491 $3K
85014 <1% 2,786 $3K
84144 <1% 292 $3K
82140 <1% 684 $3K
84402 <1% 335 $3K
82077 <1% 288 $3K
83498 <1% 360 $3K
85045 <1% 2,235 $3K
86762 <1% 646 $3K
82670 <1% 364 $3K
87116 <1% 431 $3K
85018 <1% 2,352 $3K
82150 <1% 789 $3K
82533 <1% 313 $2K
82553 <1% 616 $2K
82261 <1% 295 $2K
86003 <1% 163 $2K
83789 <1% 306 $2K
80202 <1% 308 $2K
87641 <1% 93 $2K
86235 <1% 118 $2K
83013 <1% 111 $2K
82105 <1% 225 $2K
84156 <1% 1,594 $2K
82247 <1% 811 $2K
83002 <1% 341 $2K
82977 <1% 707 $2K
82043 <1% 869 $2K
84300 <1% 793 $2K
87102 <1% 496 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 45 $2K
86787 <1% 205 $2K
86880 <1% 530 $2K
86431 <1% 395 $1K
82378 <1% 214 $1K
86376 <1% 314 $1K
80143 <1% 116 $1K
82947 <1% 612 $1K
86705 <1% 172 $1K
80179 <1% 114 $1K
86200 <1% 233 $1K
86706 <1% 183 $1K
87390 <1% 107 $1K
87522 Neg quan hep c or qual rna <1% 42 $1K
84478 <1% 550 $1K
86800 <1% 190 $1K
85007 <1% 650 $1K
84030 <1% 444 $1K
82627 <1% 197 $1K
82776 <1% 295 $1K
87511 <1% 44 $1K
87653 <1% 43 $987.26
86696 <1% 98 $959.50
82950 <1% 409 $955.30
80050 General health panel <1% 296 $883.90
89051 <1% 281 $858.24
80164 <1% 195 $856.29
88342 <1% 40 $846.65
83520 <1% 100 $817.86
84165 <1% 220 $810.99
83525 <1% 180 $806.26
84295 <1% 323 $799.71
82951 <1% 133 $793.80
86225 <1% 140 $793.35
86695 <1% 99 $780.30
83090 <1% 111 $745.80
82785 <1% 166 $735.64
84681 <1% 115 $734.35
86141 <1% 86 $723.90
83935 <1% 311 $709.48
84460 <1% 300 $692.95
84450 <1% 299 $637.18
87563 <1% 60 $631.80
85520 <1% 164 $623.67
86701 <1% 88 $575.06
86704 <1% 72 $565.20
86765 <1% 139 $562.82
87210 <1% 239 $556.60
82024 <1% 53 $544.12
87449 <1% 70 $543.86
84305 <1% 72 $542.88
82945 <1% 312 $495.92
89050 <1% 239 $485.69
84436 <1% 195 $477.12
86709 <1% 149 $476.78
82010 <1% 180 $474.54
84270 <1% 58 $472.22
86735 <1% 72 $447.87
86702 <1% 87 $446.17
84630 <1% 89 $443.14
86308 <1% 174 $412.80
86304 <1% 38 $412.30
84157 <1% 320 $401.83
87206 <1% 178 $378.00
88304 <1% 19 $357.27
86160 <1% 98 $351.12
82747 <1% 53 $346.32
84445 <1% 23 $333.18
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 12 $309.10
86665 <1% 38 $297.60
84480 <1% 135 $296.58
83930 <1% 119 $293.58
80069 <1% 68 $289.68
80197 <1% 57 $288.75
86334 <1% 32 $286.62
87338 <1% 30 $282.00
86039 <1% 52 $278.20
86147 <1% 23 $272.46
80074 <1% 15 $269.36
84154 <1% 41 $264.00
87209 <1% 35 $263.55
87045 <1% 39 $252.15
86021 <1% 57 $249.38
86780 <1% 26 $224.64
87899 <1% 43 $212.42
83993 <1% 34 $209.78
86777 <1% 33 $209.55
82542 <1% 26 $207.39
80177 <1% 40 $192.36
87220 <1% 74 $176.25
86060 <1% 40 $172.00
82310 <1% 84 $167.98
82952 <1% 88 $166.17
84134 <1% 39 $156.51
84432 <1% 20 $150.91
87077 <1% 635 $149.16
85732 <1% 41 $146.74
82390 <1% 32 $141.76
85613 <1% 39 $136.89
83883 <1% 13 $135.72
84075 <1% 67 $128.82
87177 <1% 35 $126.00
83010 <1% 27 $119.61
80178 <1% 37 $119.51
85660 <1% 49 $114.17
82274 <1% 22 $110.00
87147 <1% 67 $107.20
84155 <1% 57 $102.72
86870 <1% 15 $101.82
87046 <1% 39 $101.36
86677 <1% 14 $97.50
84163 <1% 20 $92.82
84425 <1% 14 $89.74
88141 <1% 27 $87.50
82164 <1% 20 $84.40
87625 <1% 12 $71.65
86708 <1% 15 $71.55
87184 <1% 13 $63.00
86617 <1% 14 $60.60
85390 <1% 12 $55.68
82042 <1% 18 $47.79
84590 <1% 14 $47.57
83986 <1% 24 $45.76
82272 <1% 32 $39.14
84479 <1% 20 $28.71
81050 <1% 14 $17.92
84520 <1% 13 $15.66
86923 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.